リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Secretory expression of mammalian NOTCH tandem epidermal growth factor-like repeats based on increased O-glycosylation」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Secretory expression of mammalian NOTCH tandem epidermal growth factor-like repeats based on increased O-glycosylation

张, 爱玲 名古屋大学

2023.07.31

概要

主論文の要旨

Secretory expression of mammalian NOTCH
tandem epidermal growth factor-like repeats based
on increased O-glycosylation
O-グリコシル化の増加に基づく哺乳類NOTCHタンデム
上皮成長因子様リピートの分泌発現

名古屋大学大学院医学系研究科
生体管理医学講座

麻酔・蘇生医学分野

(指導:西脇 公俊


総合医学専攻

爱玲

教授)

【Introduction】
Dysregulation of Notch signaling is associated with various cancer. Although Notch
signaling has both tumor-promoting and tumor-suppressive roles, it is considered a potential
therapeutic target for tumors because tumor angiogenesis depends on Notch signaling;
disruption of Notch signaling inhibits tumor growth by impairing angiogenesis. Thus,
establishing effective strategies to inhibit Notch signaling is of therapeutic importance. A
previous study developed a soluble form of the NOTCH1 receptor (NOTCH1 decoy) that
inhibits ligand-induced Notch signaling and tumor angiogenesis in vivo. Although the
NOTCH1 decoy molecule consists exclusively of a tandem array of epidermal growth factorlike (EGF) repeats, the expressed proteins are poorly secreted into the culture media and are
predominantly retained within the cells. NOTCH EGF repeats are modified with specific Oglycans, including O-fucose, O-glucose, and O-GlcNAc, which are catalyzed by POFUT1,
POGLUT1, and EOGT, respectively. Previous studies have revealed that POFUT1 and
POGLUT1 affect the cell surface expression of endogenous NOTCH1 in various cell types,
including HEK293T cells. Thus, optimal expression of EGF domain-specific glycosyltransferases
may improve the production of full-length NOTCH EGF repeats.
In this study, we evaluated the effects of overexpressed EGF domain-specific Oglycosyltransferases, including POFUT1, POGLUT1, and EOGT, on the secretion of NOTCH
EGF repeats in HEK293T cells. Our results reveal a novel function of EOGT in promoting the
secretion of recombinantly expressed NOTCH1 EGF repeats.
【Method】
We exogenously expressed EOGT in HEK293T cells to prepare a culture medium containing
NOTCH1 EGF repeats. The plasmid construct encoding the entire NOTCH1 EGF repeat with
an N-terminal FLAG tag (FLAG:N1-EGF) was generated and transfected into HEK293T cells
with or without EOGT. Culture media containing FLAG:N1-EGF were incubated with DLL4
ligand-expressing cells and analyzed by FACS. Next, we examined the combined effects of
glycosyltransferases acting on NOTCH EGF domains in the endoplasmic reticulum (ER),
including POFUT1, POGLUT1, and EOGT. Because a previous study on Drosophila POFUT1
homologue indicated that glycosyltransferases could promote NOTCH secretion in an enzyme
activity-independent manner, we analyzed the impact of enzymatically inactive mutants of
EOGT and POGLUT1. To evaluate changes in the O-glycosylation states of EGF repeats
mediated by the co-expression of EOGT and POGLUT1, mass spectrometric analysis was
performed. We selected FLAG-tagged NOTCH3 EGF repeats (FLAG:N3-EGF) for analysis
because of the abundance of the purified proteins.
【Result】
First, we confirmed that with EOGT overexpression the amount of FLAG:N1-EGF bound to

-1-

ligand-expressing cells was significantly increased. At the same time, the amount of FLAG:N1EGF in the culture media was elevated. These results suggest that EOGT possesses a novel but
seemingly physiologically irrelevant ability to promote the secretion of EGF repeats of
NOTCH1, which at least partially contributes to increased binding to DLL4. Next, we prepared
culture media and cell lysates to analyze the amount of FLAG:N1-EGF, FLAG:N3-EGF
secretion. Immunoblotting results indicated that FLAG:N1-EGF secreted in the culture media
was increased by co-expression of EOGT. Despite the roles of POFUT1 and POGLUT1 in the
secretory pathway, the effect of POFUT1 or POGLUT1 overexpression on FLAG:N1-EGF
NOTCH1 secretion was not statistically significant in HEK293T cells. In contrast, coexpression of EOGT/POGLUT1, but not EOGT/POFUT1, further increased secretion
compared with EOGT alone. Also, FLAG:N3-EGF secreted in culture media was increased by
co-expression of EOGT/POGLUT1. Quantification of secreted FLAG:N1-EGF from EOGT
mutant HEK293T cells co-expressing inactive EOGT harboring the R377Q mutation showed
that EOGT R377Q failed to facilitate secretion into the culture media. Co-expression of
POGLUT1 R279W slightly increased the secretion of FLAG:N1-EGF, but to a lesser extent than
that of wild-type POGLUT1. These data suggested that enzyme activity is essential for the
effect of EOGT on the promotion of FLAG:N1-EGF secretion. The optimal combination of
ER-resident glycosyltransferases serves as a strategy for efficiently producing EGF repeats of
various NOTCH family members based on the engineered expression of glycosyltransferases.
Finally, we adopted the label-free quantitation workflow in Proteome Discoverer with Byonic
node, a search engine suitable for glycopeptide identification from MS/MS spectra. Consistent
with the O-GlcNAc transferase activity of EOGT, the abundance ratio of HexNAc-modified
glycopeptides corresponding to O-GlcNAc, O-GlcNAc-Gal, or O-GlcNAc-Gal-NeuAc glycoforms
was markedly increased at EGF9, 10, 25, 31, and 34 by EOGT/POGLUT1 overexpression. In
contrast, the effect on EGF4, 14, 18, and 30 was limited because O-GlcNAcylation occurs at
high stoichiometries regardless of the exogenously expressed glycosyltransferases. These data
support our proposal that elevated O-GlcNAc modifications promote the secretion of NOTCH
EGF repeats. Lack of these constitutive modifications may contribute to the reduced secretion
efficiency of NOTCH EGF repeats in EOGT mutant cells. Unlike in the case of O-GlcNAc
modification, the effect of EOGT/POGLUT1 on O-Glc modification was obscure because all
detectable

O-Glc

sites

on

FLAG:N3-EGF

were

mostly

O-glycosylated

without

EOGT/POGLUT1 overexpression. However, that NOTCH EGF repeats with insufficient Oglycosylation are not secreted and, therefore, not detected by mass spectrometry of secreted
proteins in the culture medium. Expression of POGLUT1 may reduce the proportion of
insufficiently O-glucosylated NOTCH EGF, which is otherwise retained in the cells.
【Conclusion】
This study suggests that combining ER-resident EGF domain-specific glycosyltransferases

-2-

improved the amount of secreted NOTCH EGF repeats in the culture media. Notably, we
showed for the first time that EOGT has the potential to promote the secretory expression of
NOTCH EGF repeats. We speculated that overexpressing these glycosyltransferases is
effective in the sensitized condition where NOTCH EGF repeats are prone to be under-Oglycosylated. The altered O-glycosylation states of NOTCH EGF repeats were evaluated by
mass spectrometry using the simplified label-free quantitation workflow of Proteome
Discoverer. These strategies are applicable to the production and quality control of full-length
NOTCH EGF repeats for use as pharmaceuticals effective against diseases, including various
cancers.

-3-

この論文で使われている画像

参考文献

[1] O. Meurette, P. Mehlen, Notch signaling in the tumor microenvironment, Cancer

Cell 34 (4) (2018) 536–548.

[2] J. Dufraine, Y. Funahashi, J. Kitajewski, Notch signaling regulates tumor

angiogenesis by diverse mechanisms, Oncogene 27 (38) (2008) 5132–5137.

[3] Y. Funahashi, S.L. Hernandez, I. Das, A. Ahn, J. Huang, M. Vorontchikhina, et al.,

A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth,

and angiogenesis, Cancer Res. 68 (12) (2008) 4727–4735, https://doi.org/

10.1158/0008-5472.CAN-07-6499. Epub 2008/06/19, PubMed PMID: 18559519;

PubMed Central PMCID: PMCPMC3690602.

[4] T. Kangsamaksin, A. Murtomaki, N.M. Kofler, H. Cuervo, R.A. Chaudhri, I.

W. Tattersall, et al., NOTCH decoys that selectively block DLL/NOTCH or JAG/

NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth,

Cancer Discov. 5 (2) (2015) 182–197, https://doi.org/10.1158/2159-8290.Cd-140650. PubMed PMID: WOS:000349393600026.

[5] P. Stanley, T. Okajima, Roles of glycosylation in Notch signaling, Curr. Top. Dev.

Biol. 92 (2010) 131–164, https://doi.org/10.1016/S0070-2153(10)92004-8. Epub

2010/09/08, PubMed PMID: 20816394.

[6] H. Takeuchi, R.S. Haltiwanger, Significance of glycosylation in Notch signaling,

Biochem. Biophys. Res. Commun. 453 (2) (2014) 235–242.

[7] M. Ogawa, T. Okajima, Structure and function of extracellular O-GlcNAc, Curr.

Opin. Struct. Biol. 56 (2019) 72–77, https://doi.org/10.1016/j.sbi.2018.12.002.

Epub 2019/01/23, PubMed PMID: 30669087.

[8] P.-W. Lo, T. Okajima, Eogt-catalyzed O-GlcNAcylation, Trends Glycosci.

Glycotechnol. 34 (197) (2022) E1–E6.

[9] R. Ajima, E. Suzuki, Y. Saga, Pofut1 point-mutations that disrupt Ofucosyltransferase activity destabilize the protein and abolish Notch1 signaling

during mouse somitogenesis, PLoS One 12 (11) (2017), e0187248.

[10] H. Takeuchi, H.J. Yu, H.L. Hao, M. Takeuchi, A. Ito, H.L. Li, et al., O-Glycosylation

modulates the stability of epidermal growth factor-like repeats and thereby

regulates Notch trafficking, J. Biol. Chem. 292 (38) (2017) 15964–15973, https://

doi.org/10.1074/jbc.M117.800102. PubMed PMID: WOS:000411512200032.

[11] M.B. Andrawes, X. Xu, H. Liu, S.B. Ficarro, J.A. Marto, J.C. Aster, et al., Intrinsic

selectivity of notch 1 for delta-like 4 over delta-like 1, J. Biol. Chem. 288 (35)

(2013) 25477–25489.

[12] H. Meng, X. Zhang, G. Yu, S.J. Lee, Y.E. Chen, I. Prudovsky, et al., Biochemical

characterization and cellular effects of CADASIL mutants of NOTCH3, PLoS One 7

(9) (2012), e44964, https://doi.org/10.1371/journal.pone.0044964. Epub 2012/

10/03, PubMed PMID: 23028706; PubMed Central PMCID: PMCPMC3445613.

[13] Y. Sakaidani, N. Ichiyanagi, C. Saito, T. Nomura, M. Ito, Y. Nishio, et al., O-linkedN-acetylglucosamine modification of mammalian Notch receptors by an atypical OGlcNAc transferase Eogt1, Biochem. Biophys. Res. Commun. 419 (1) (2012) 14–19,

https://doi.org/10.1016/j.bbrc.2012.01.098. Epub 2012/02/09, PubMed PMID:

22310717.

[14] M. Ogawa, S. Sawaguchi, T. Kawai, D. Nadano, T. Matsuda, H. Yagi, et al.,

Impaired O-linked N-acetylglucosaminylation in the endoplasmic reticulum by

mutated epidermal growth factor (EGF) domain-specific O-linked Nacetylglucosamine transferase found in Adams-Oliver syndrome, J. Biol. Chem.

290 (4) (2015) 2137–2149, https://doi.org/10.1074/jbc.M114.598821. PubMed

PMID: 25488668; PubMed Central PMCID: PMC4303666.

4. Conclusion

The Notch signaling pathway is precisely controlled during animal

development, and dysregulation of this pathway is associated with

various diseases, including cancer. NOTCH EGF repeats serve as decoy

molecules that are expected to interact with ligands and thus inhibit

ligand-dependent Notch signaling, which is expected to disrupt tumor

angiogenesis. Although full-length NOTCH EGF repeats exhibit potent

Notch inhibitor activity, they are poorly secreted from cells compared to

partial EGF repeats in cultured cells. This study suggests that combining

ER-resident EGF domain-specific glycosyltransferases improved the

amount of secreted NOTCH EGF repeats in the culture media. Notably,

we showed for the first time that EOGT has the potential to promote the

secretory expression of NOTCH EGF repeats. We speculated that over­

expressing these glycosyltransferases is effective in the sensitized con­

dition where NOTCH EGF repeats are prone to be under-O-glycosylated.

The altered O-glycosylation states of NOTCH EGF repeats were evalu­

ated by mass spectrometry using the simplified label-free quantitation

workflow of Proteome Discoverer. These strategies are applicable to the

production and quality control of full-length NOTCH EGF repeats for use

as pharmaceuticals effective against diseases, including various cancers

[28].

CRediT authorship contribution statement

AZ: Visualization, investigation, data curation, formal analysis, re­

sources, methodology, validation, writing - original draft preparation.

YoT: Visualization, investigation, data curation, formal analysis, re­

sources, methodology, and validation. HT: Funding acquisition, project

administration, supervision, validation, writing, review, and editing.

KN: Project administration and supervision. YuT: Visualization, inves­

tigation, data curation, formal analysis, resources, methodology, and

validation. TO: conceptualization, funding acquisition, project admin­

istration, supervision, writing - original draft preparation, writing 7

A. Zhang et al.

Analytical Biochemistry 656 (2022) 114881

[21] S. Yu, W. Wang, M. Albakri, X. Yu, G. Majihail, S. Lim, et al., O-Fucose and Fringemodified NOTCH1 extracellular domain fragments as decoys to release nichelodged hematopoietic progenitor cells, Glycobiology 31 (5) (2021) 582–592.

[22] T. Okajima, A. Xu, L. Lei, K.D. Irvine, Chaperone activity of protein Ofucosyltransferase 1 promotes notch receptor folding, Science 307 (5715) (2005)

1599–1603.

[23] D.J. Ralser, H. Takeuchi, G. Fritz, F.B. Basmanav, M. Effern, S. Sivalingam, et al.,

Altered Notch signaling in Dowling-Degos disease: additional mutations in

POGLUT1 and further insights into disease pathogenesis, J. Invest. Dermatol. 139

(4) (2019) 960.

[24] J.F. Arboleda-Velasquez, R. Rampal, E. Fung, D.C. Darland, M. Liu, M.C. Martinez,

et al., CADASIL mutations impair Notch3 glycosylation by Fringe, Hum. Mol.

Genet. 14 (12) (2005) 1631–1639.

[25] S. Kakuda, R.S. Haltiwanger, Deciphering the fringe-mediated notch code:

identification of activating and inhibiting sites allowing discrimination between

ligands, Dev. Cell 40 (2) (2017) 193–201, https://doi.org/10.1016/j.

devcel.2016.12.013. Epub 2017/01/17, PubMed PMID: 28089369; PubMed

Central PMCID: PMCPMC5263050.

[26] M. Bern, Y.J. Kil, C. Becker, Byonic: advanced peptide and protein identification

software, Current protocols in bioinformatics 40 (1) (2012), 13.20. 1-13.20. 14.

[27] H. Hashiguchi, Y. Tsukamoto, M. Ogawa, Y. Tashima, H. Takeuchi, M. Nakamura,

et al., Glycoproteomic analysis identifies cryptdin-related sequence 1 as Oglycosylated protein modified with α1, 2-fucose in the small intestine, Arch.

Biochem. Biophys. 695 (2020), 108653.

[28] W. Wang, T. Okajima, H. Takeuchi, Significant roles of notch O-glycosylation in

cancer, Molecules 27 (6) (2022) 1783.

[15] S.M.D. Alam, Y. Tsukamoto, M. Ogawa, Y. Senoo, K. Ikeda, Y. Tashima, et al., NGlycans on EGF domain-specific O-GlcNAc transferase (EOGT) facilitate EOGT

maturation and peripheral endoplasmic reticulum localization, J. Biol. Chem. 295

(25) (2020) 8560–8574, https://doi.org/10.1074/jbc.RA119.012280. Epub 2020/

05/08, PubMed PMID: 32376684; PubMed Central PMCID: PMCPMC7307186.

[16] Y. Urata, W. Saiki, Y. Tsukamoto, H. Sago, H. Hibi, T. Okajima, et al., Xylosyl

extension of O-glucose glycans on the extracellular domain of NOTCH1 and

NOTCH2 regulates notch cell surface trafficking, Cells 9 (5) (2020), https://doi.

org/10.3390/cells9051220. Epub 2020/05/20, PubMed PMID: 32423029;

PubMed Central PMCID: PMCPMC7291291.

[17] M. Ogawa, Y. Tashima, Y. Sakaguchi, H. Takeuchi, T. Okajima, Contribution of

extracellular O-GlcNAc to the stability of folded epidermal growth factor-like

domains and Notch1 trafficking, Biochem. Biophys. Res. Commun. 526 (1) (2020)

184–190, https://doi.org/10.1016/j.bbrc.2020.03.066. Epub 2020/03/24,

PubMed PMID: 32201074.

[18] D.J. Ralser, H. Takeuchi, G. Fritz, F.B. Basmanav, M. Effern, S. Sivalingam, et al.,

Altered notch signaling in dowling-degos disease: additional mutations in

POGLUT1 and further insights into disease pathogenesis, J. Invest. Dermatol. 139

(4) (2019) 960–964, https://doi.org/10.1016/j.jid.2018.10.030. Epub 2018/11/

12, PubMed PMID: 30414910; PubMed Central PMCID: PMCPMC6431572.

[19] S. Sawaguchi, S. Varshney, M. Ogawa, Y. Sakaidani, H. Yagi, K. Takeshita, et al., OGlcNAc on NOTCH1 EGF repeats regulates ligand-induced Notch signaling and

vascular development in mammals, Elife 6 (2017). PubMed PMID: Medline:

28395734.

[20] Y. Tsukamoto, M. Ogawa, K. Yogi, Y. Tashima, H. Takeuchi, T. Okajima,

Glycoproteomics of NOTCH1 EGF repeat fragments overexpressed with different

glycosyltransferases in HEK293T cells reveals insights into O-GlcNAcylation of

NOTCH1, Glycobiology 32 (7) (2022) 616–628.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る